News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biotech Firm Vaxin, Inc. Taps New CEO, Looks for VC Funds



8/8/2008 7:00:28 AM

Vaxin Inc. nabbed its new CEO from a competitor and charged him with soliciting $20 million in venture capital to transition the biotech firm's experimental flu drugs into commercial products.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES